• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Aiforia's H1 revenue was surprisingly subdued

AIFORIAAnalyst Comment22.07.2026 klo 09.05
Antti SiltanenAnalyst
Discuss

Summary

  • Aiforia's revenue for January-June was approximately 0.75 MEUR, a 46% decrease from the previous year, falling short of both company and analyst expectations.
  • The company attributes the weak performance to delays in customer contracts and expects revenue from new contracts to be recognized in the second half of the year.
  • Aiforia's order book at the end of H1 was 3.5 MEUR, down from 5.1 MEUR a year ago, indicating slower growth in recurring revenue.
  • Despite the revenue shortfall, Aiforia's recent 6.4 MEUR funding is deemed sufficient until H1'27, with additional potential financing from the European Investment Bank.

This content is generated by AI. You can give feedback on it in the Inderes forum.

Translation: Original published in Finnish on 07/22/2026 at 08:23 am EEST

Aiforia announced on Tuesday that its revenue for the beginning of the year has turned out clearly below the company's own and our expectations. The company estimates that January–June revenue will decrease significantly from the comparison period to around 0.75 MEUR (H1'25: 1.4 MEUR). According to the company, revenue from new customers announced in H1 should materialize in H2. In recent years, the company has announced several customer wins, but their conversion into significant recurring revenue seems to be taking a long time. The profit warning naturally has a negative impact on our estimates and investment view, which we will update in the near future.

Slow revenue recognition from customer contracts is slowing growth

Aiforia's January-June revenue of around 0.75 MEUR represents a decrease of approximately 46% compared to the comparison period. The outcome falls sharply short of our expectations, as we had estimated revenue of 2.3 MEUR for the beginning of the year, following a successful H2'25. According to the company, the weak performance was due to delays in ongoing customer contracts and the fact that revenue from new contracts signed during the early part of the year (such as the Paris and Spain hospital expansions) will only start to be recognized in the second half of the year. The company has consistently reported new customer accounts over the past couple of years, but the recurring revenue generated from them is still very modest and appears to be growing slowly. In Aiforia's business model, the value of contracts is recognized as revenue based on usage, which makes the growth rate highly sensitive to the schedules of customers' own processes. The order book of 3.5 MEUR at the end of H1 provides support for future revenue development. However, the order book is modest compared to a year ago (H1'25: 5.1 MEUR).

Funding is sufficient for next year even without the EIB loan

The company stated that the weak performance in the beginning of the year does not cause revisions to its previously issued mid-term targets. However, the sluggishness in H1 means clear downward pressure on our 2026 estimates, as our expected growth curve is once again pushed forward. Regarding funding, Aiforia recently raised 6.4 MEUR through a directed issue. We believe this funding is sufficient until H1'27. In addition, the company has a letter of intent for 20 MEUR in venture debt financing with the European Investment Bank. The slow progress of the company also increases uncertainty from a financing perspective.

Login required

This content is only available for logged in users

Create account

Aiforia Technologies equips pathologists and researchers in preclinical and clinical laboratories with software to translate images into discoveries, decisions and diagnoses. The company's products and services are used for medical image analysis, across a variety of fields such as oncology and neuroscience. Aiforia Technologies is headquartered in Finland.

Read more on company page

Key Estimate Figures09.03.

202526e27e
Revenue3.55.17.9
growth-%24.0 %45.0 %55.0 %
EBIT (adj.)-11.2-9.2-8.3
EBIT-% (adj.)-316.3 %-178.7 %-104.7 %
EPS (adj.)-0.38-0.25-0.19
Dividend0.000.000.00
Dividend %
P/E (adj.)neg.neg.neg.
EV/EBITDAneg.neg.neg.

Forum discussions

I am particularly interested in the H1 cash flow statement, and going forward, I need to focus on that in the case of Aiforia as well, because...
2 hours ago
12
Same thought. Aiforia hasn’t really offered much else besides stories and tax deductions at the turn of the year. Luckily, I didn’t add to my...
5 hours ago
by Pyynikin patruuna
6
This profit warning marked the final bursting of the Aiforia bubble in my eyes. The management’s talk has been tough over the years, and the...
8 hours ago
47
Customer contracts are being delayed, but for what reason? Could @Antti_Siltanen find out more about this? Scanners, implementation, or what...
10 hours ago
by Matti
6
It seems Jukka is living somewhere around the Riviera. The gentleman does not appear to be a tax resident of Finland, and besides, he was on...
10 hours ago
by Tmpr2000
3
However, the Board of Directors (HPJ) is largely dependent on the information provided by the CEO (TJ). While they have certainly made their...
10 hours ago
by TZ
1
The road is often rocky for an AI boutique at the start, but this is on Inderes’ Model Portfolio with a “Buy” recommendation. Personally, I ...
11 hours ago
by Kunhalvallasaa
5